Aripiprazole in Children With Autism: A Pilot Study

Summary

This is a 6-week open pilot study of aripiprazole for the treatment of adolescents, aged 12 to 18 years, diagnosed with autism. Children who qualify for the study will be treated with aripiprazole for 6 weeks. Treatment is provided at no cost.

Timeline

Start

2004-02

Primary completion

2011-11-16

Completion

2011-11-16

Drugs

Indications